Angiotensin receptor blockers (ARBs), particularly losartan, are associated with a lower risk for incident epilepsy in patients with hypertension and no preexisting stroke or cardiovascular disease ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease ...

Hypertension control is critical to prevent stroke. With several clinical trials conducted over the last decade, it seems that the use of an angiotensin-modulating antihypertensive agent conveys ...

Losartan may help stop the epileptic process in certain patients with hypertension. An observational study that analyzed medical records of 2.26 million patients with hypertension found a roughly 30% ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...

(HealthDay News) — Angiotensin receptor blockers (ARBs) are just as effective and safe as angiotensin-converting enzyme inhibitors (ACEIs), according to research published in Mayo Clinic Proceedings.

Researchers found that the incidence of epilepsy was reduced with use of ARBs vs ACEs, β-blockers, and a combination of other antihypertensive classes. HealthDay News — For patients with hypertension, ...

Background: Hepatitis B virus (HBV) infection is a common cause of liver-related morbidity and mortality. Evidence suggests that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II ...

Patients are more likely to continue to take angiotensin-receptor blockers compared with other classes of blood pressure drugs, according to the findings of a meta-analysis by US researchers. The ...